Home › Funds › Royce & Associates › TMDX

Royce & Associates position in TMDX

TRANSMEDICS GROUP INC · Health Care

Latest position (Q1 2026)244.38K sh
Reported value held$24.29M
Portfolio Weight0.24%
First reportedQ4 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q4 2021 61.00K $1.17M New
Q1 2022 87.00K $2.34M Add
Q2 2022 142.00K $4.47M Add
Q3 2022 152.00K $6.34M Add
Q4 2022 192.00K $11.85K Add
Q1 2023 159.50K $12.08K Reduce
Q2 2023 137.50K $11.55M Reduce
Q3 2023 141.70K $7.76M Add
Q4 2023 351.70K $27.76M Add
Q1 2024 315.20K $23.31M Reduce
Q2 2024 301.20K $45.37M Reduce
Q3 2024 297.20K $46.66M Reduce
Q4 2024 297.20K $18.53M Hold
Q1 2025 297.20K $20.00M Hold
Q2 2025 247.40K $33.15M Reduce
Q3 2025 243.15K $27.28M Reduce
Q4 2025 243.15K $29.58M Hold
Q1 2026 244.38K $24.29M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding TMDX

All TMDX fund holders →